Predicting the Survival of Triple-Negative Breast Cancer in Different Stages: A SEER Population Based Research Referring to Clinicopathological Factors-Reference-Cited by-同舟云学术

Predicting the Survival of Triple-Negative Breast Cancer in Different Stages: A SEER Population Based Research Referring to Clinicopathological Factors

Published:2020-10-15 Issue:10 Volume:38 Page:549-558
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Chen Si-Si¹,Tang Shou-Ching²,Li Kai¹,Wu Jie¹,Li Xiang¹,Ren Hong¹,Sun Xin¹

Affiliation:

1. Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an City, China

2. University of Mississippi Medical Center, Center and Research Institute, Jackson, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2020.1831010

Reference32 articles.

1. Cancer statistics, 2017

2. Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers

3. Triple-negative breast cancer: epidemiological considerations and recommendations

4. Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients;Expert Review of Anticancer Therapy;2024-02-23

2. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?;Breast Cancer: Targets and Therapy;2023-05

3. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database;Clinical Breast Cancer;2023-04

4. Nomogram for Predicting Overall Survival and Assessing the Survival Benefit of Adjuvant Treatment in pT1-2N0M0 Triple-Negative Breast Cancer: A Surveillance, Epidemiology, and End Results-Based Study;Frontiers in Oncology;2022-02-25

5. Intravenous Immunoglobulin to Suppress Progression in a Patient With Advanced Breast Cancer;Journal of Breast Cancer;2022